Atlas Trials

Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine

Clinical trial NCT02095314 · COMPLETED

Trial details

NCT number
NCT02095314
Sponsor
PT Bio Farma
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Healthy
Start date
2014-03-01
Primary completion
2014-06-01
Enrollment
399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.